Literature DB >> 2548078

Use of a glucocorticoid-inducible promoter for expression of herpes simplex virus type 1 glycoprotein gC1, a cytotoxic protein in mammalian cells.

H M Friedman1, A Yee, H Diggelmann, J C Hastings, R Tal-Singer, C A Seidel-Dugan, R J Eisenberg, G H Cohen.   

Abstract

Abundant expression of herpes simplex virus type 1 glycoprotein gC (gC1) in transfected mammalian cells has not previously been achieved, possibly because gC1 protein is toxic to cells. To approach this problem, the gC1 coding sequence was placed under the control of the weak but inducible glucocorticoid-responsive promoter from the mouse mammary tumor virus (MMTV) long terminal repeat (LTR). As controls to evaluate for gC1 cytotoxicity, the MMTV LTR promoter was used to express glycoprotein gD1, and a strong, constitutive promoter from the Moloney murine sarcoma virus LTR was used to express gC1. L cells were transfected with these constructs, and a clone expressing gC1 from the inducible MMTV LTR promoter was analyzed. In the absence of glucocorticoid (dexamethasone) stimulation, only a low level of gC1 mRNA expression was detected; after overnight stimulation with dexamethasone, transcription increased approximately 200-fold. Abundant gC1 protein that was functionally active in that it bound complement component C3b, was produced. From passages 5 through 26 (70 cell population doublings), the gC1-producing clone became less responsive to overnight dexamethasone stimulation. The block to gC1 expression occurred at the level of transcription and was associated with hypermethylation of the MMTV LTR DNA. Treatment of the clone with 5-aza-2'-deoxycytidine partially reversed the block in gC1 protein production. Late-passage cells assumed a gC1-negative phenotype that appeared to offer a selective growth advantage, which suggested that gC1 was cytotoxic. Several findings support this view: (i) some cells expressing gC1 after overnight stimulation with dexamethasone assumed bizarre, syncytial shapes; (ii) continuous stimulation with dexamethasone for 5 weeks resulted in death of most cells; (iii) cells transfected with gC1 under the control of the strong Moloney murine sarcoma virus promoter assumed bizarre shapes, and stable gC1-expressing clones could not be established; and (iv) cells induced to express gD1 retained a normal appearance after overnight stimulation or 15 weeks of continuous stimulation with dexamethasone. The inducible MMTV LTR promoter is useful for expressing gC1 and may have applications for expressing other cytotoxic proteins.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2548078      PMCID: PMC362303          DOI: 10.1128/mcb.9.6.2303-2314.1989

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  56 in total

1.  Localization and synthesis of an antigenic determinant of herpes simplex virus glycoprotein D that stimulates the production of neutralizing antibody.

Authors:  G H Cohen; B Dietzschold; M Ponce de Leon; D Long; E Golub; A Varrichio; L Pereira; R J Eisenberg
Journal:  J Virol       Date:  1984-01       Impact factor: 5.103

2.  Binding of complement component C3b to glycoprotein gC of herpes simplex virus type 1: mapping of gC-binding sites and demonstration of conserved C3b binding in low-passage clinical isolates.

Authors:  H M Friedman; J C Glorioso; G H Cohen; J C Hastings; S L Harris; R J Eisenberg
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

3.  Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cells.

Authors:  H M Friedman; G H Cohen; R J Eisenberg; C A Seidel; D B Cines
Journal:  Nature       Date:  1984 Jun 14-20       Impact factor: 49.962

4.  Hormonal regulation of the Rous sarcoma virus src gene via a heterologous promoter defines a threshold dose for cellular transformation.

Authors:  E B Jakobovits; J E Majors; H E Varmus
Journal:  Cell       Date:  1984-10       Impact factor: 41.582

5.  Use of the mouse mammary tumor virus long terminal repeat to promote steroid-inducible expression of v-mos.

Authors:  J Papkoff; G M Ringold
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

6.  Dexamethasone increases the number of RNA polymerase II molecules transcribing integrated mouse mammary tumor virus DNA and flanking mouse sequences.

Authors:  J M Firzlaff; H Diggelmann
Journal:  Mol Cell Biol       Date:  1984-06       Impact factor: 4.272

7.  Detection of antibodies to herpes simplex virus with a continuous cell line expressing cloned glycoprotein D.

Authors:  P W Berman; D Dowbenko; L A Lasky; C C Simonsen
Journal:  Science       Date:  1983-11-04       Impact factor: 47.728

8.  A small region of the mouse mammary tumor virus long terminal repeat confers glucocorticoid hormone regulation on a linked heterologous gene.

Authors:  J Majors; H E Varmus
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

9.  The region of mouse mammary tumor virus DNA containing the long terminal repeat includes a long coding sequence and signals for hormonally regulated transcription.

Authors:  N Fasel; K Pearson; E Buetti; H Diggelmann
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

10.  Molecularly cloned c-mos(rat) is biologically active.

Authors:  F A van der Hoorn; E Hulsebos; A J Berns; H P Bloemers
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

View more
  9 in total

1.  Simple piggyBac transposon-based mammalian cell expression system for inducible protein production.

Authors:  Zhijie Li; Iacovos P Michael; Dongxia Zhou; Andras Nagy; James M Rini
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-08       Impact factor: 11.205

2.  Immune evasion properties of herpes simplex virus type 1 glycoprotein gC.

Authors:  H M Friedman; L Wang; N O Fishman; J D Lambris; R J Eisenberg; G H Cohen; J Lubinski
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

3.  Herpes simplex virus type 1 encodes two Fc receptors which have different binding characteristics for monomeric immunoglobulin G (IgG) and IgG complexes.

Authors:  G Dubin; I Frank; H M Friedman
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

4.  Programmed killing of human cells by means of an inducible clone of parvoviral genes encoding non-structural proteins.

Authors:  P Caillet-Fauquet; M Perros; A Brandenburger; P Spegelaere; J Rommelaere
Journal:  EMBO J       Date:  1990-09       Impact factor: 11.598

5.  The insulin degrading enzyme binding domain of varicella-zoster virus (VZV) glycoprotein E is important for cell-to-cell spread and VZV infectivity, while a glycoprotein I binding domain is essential for infection.

Authors:  Mir A Ali; Qingxue Li; Elizabeth R Fischer; Jeffrey I Cohen
Journal:  Virology       Date:  2009-02-23       Impact factor: 3.616

6.  Receptor properties of two varicella-zoster virus glycoproteins, gpI and gpIV, homologous to herpes simplex virus gE and gI.

Authors:  V Litwin; W Jackson; C Grose
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

7.  In vivo role of complement-interacting domains of herpes simplex virus type 1 glycoprotein gC.

Authors:  J Lubinski; L Wang; D Mastellos; A Sahu; J D Lambris; H M Friedman
Journal:  J Exp Med       Date:  1999-12-06       Impact factor: 14.307

8.  The herpes virus Fc receptor gE-gI mediates antibody bipolar bridging to clear viral antigens from the cell surface.

Authors:  Blaise Ndjamen; Alexander H Farley; Terri Lee; Scott E Fraser; Pamela J Bjorkman
Journal:  PLoS Pathog       Date:  2014-03-06       Impact factor: 6.823

9.  NF-κB p65 Attenuates Cardiomyocyte PGC-1α Expression in Hypoxia.

Authors:  Inna Rabinovich-Nikitin; Alexandra Blant; Rimpy Dhingra; Lorrie A Kirshenbaum; Michael P Czubryt
Journal:  Cells       Date:  2022-07-13       Impact factor: 7.666

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.